To test the causal role of defective TE in the resistance to anti-tumor immune response, we chronically stimulated B16/F10 mouse melanoma cells with sublethal doses (25 nM) of flavopiridol, an inhibitor of the RNAP II elongation factor p-TEFb (Cyclin T/CDK9). Here, CDK9 is linked to melanoma.